Newsletters

MHH Doctoral Student Receives Research Grant to Develop More Sustainable Methods for Cultivating Stem Cells

[Hannover Medical School ] The Joachim Herz Foundation has selected the postdoc Carlos Hernandez Bautista, PhD student in the "Regenerative Sciences" PhD program at Hannover Medical School (MHH) and his project "Development of sustainable biomedicine for heart regeneration" for the "Add-on Fellowship for Interdisciplinary Life Science" and is supporting him with a grant of 15,000 euros.

Renowned Developmental Biologist Wins March of Dimes Prize

[March of Dimes] March of Dimes announced leading hematologist and stem cell scientist Dr. Leonard Zon as the winner of the 2026 March of Dimes Richard B Johnston Jr, MD Prize for his work in developmental biology.

A Tunable Coacervate Matrix Emulates Embryonic Extracellular Matrix (ECM) Biophysical Cues to Regulate Stem Cell Fate

[Journal of the American Chemical Society] Researchers introduced a gelatin-based coacervate matrix with phase-transition-mediated tunable mechanics to recapitulate the biophysical cues of pre- and peri-implantation stages.

α-Satellite RNA Marks the Perinucleolar Compartment and Represses Ribosomal RNA Expression in Naive Human Embryonic Stem Cells

[Genes & Development] Scientists compared the dynamics of cytoplasmic versus chromatin-bound transcriptomes of naive and primed hESCs as well as fibroblasts. They found a remarkable enrichment for RNA transcribed from α-satellite repeat in the chromatin fraction of naive hESCs compared with primed hESCs.

Investigation of Nanoscale Topography and Biomechanical Tuning of PDMS Substrates to Enhance Cardiomyocyte Differentiation from Human Induced Pluripotent Stem Cells

[Biomaterials Science] Human fetal cardiomyocytes were isolated and their natural geometrical micro/nanotopography was imprinted on polydimethylsiloxane (PDMS) surfaces with different stiffnesses combined with tailored biochemical factors, and the impact of the three factors on the differentiation of hiPSC-derived CM was evaluated.

Highly Efficient Induction of Sox9+ Scl-Progenitors from Embryonic Stem Cells for Skeletal Modeling

[Stem Cells] Investigators developed a fast and efficient strategy to generate sclerotomal progenitors by accelerated induction from primitive streak through modulating BMP and SHH signaling, achieving an 86.9% differentiation efficiency.

Zinc Dynamics in the Pluripotent Stem Cells during Maintenance of Pluripotency and Pancreatic Differentiation

[Scientific Reports] Researchers aimed to reveal the zinc dynamics in the pluripotent PSCs and during pancreatic differentiation. Using a 67Zn-stable isotope-replaced medium, they measured zinc uptake into cells in undifferentiated iPSCs and during pancreatic differentiation.

ColonyQuant: Automated Quantification and Morphometric Analysis of Pluripotent Stem Cell Colonies

[BMC Bioinformatics] Scientists developed ColonyQuant, an open-source platform that integrates automated colony segmentation, alkaline phosphatase intensity quantification, morphometric profiling, and statistical classification into a single workflow.

STOML2 Maintains Pluripotency and Cell Cycle Integrity in Human Pluripotent Stem Cells via PHB-ERK Signaling

[International Journal of Stem Cells] The authors identified STOML2 as a key pluripotency regulator and provides new insight into intrinsic stem cell fate control. To identify novel regulators of hPSC proliferation, transcriptomic profiling of undifferentiated hPSCs and somatic cells was performed via next-generation sequencing.

From hPSCs to MSCs: Differentiation Strategies, Pathways, and the Emergence of Common Regulatory Networks

[Cellular & Molecular Biology Letters] Scientists discuss current strategies for differentiating hPSCs into mesenchymal stem cells (MSCs) and summarize the key signaling pathways, with a focus on the transcriptional regulators that govern these lineage-specific differentiation routes.

Clinical Applications of Induced Pluripotent Stem Cell-Mediated Therapies in Cancer: Progress, Challenges, and Future Directions

[Regenerative Medicine] The authors explore the potential iPSCs offer in cancer therapy, challenges such as teratoma formation, high production costs, and scalability issues. Futhermore, they investigate the use of iPSC-derived immune cells and regenerative therapies in treating various cancers.

Verdiva Bio Announces Completion of Enrollment for EVOLVE-2 Phase IIb Study of VRB-101, a Potential Once-Weekly Oral GLP-1 Peptide Analog in Individuals with Obesity

[Verdiva Bio Limited] Verdiva Bio Limited announced the completion of enrollment for its Phase IIb EVOLVE-2 clinical study of VRB-101, a once-weekly oral, cAMP-biased, GLP-1 peptide analog candidate for body weight reduction in people with overweight or obesity.
spot_img